BDX — Becton, Dickinson and Company
$198.91-0.75%
Last close: · regular session
Last 60 sessions
BDX closed at $198.91 (-0.75%) on Oct 23, 2026. Float: 274.6M shares. Latest SEC filing: 11-K on Jun 29, 2026.
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for BDX in the TickerWise workspace.
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Company profile
- Sector: Healthcare
- Industry: Medical - Instruments & Supplies
- Country: US
- Exchange: NYSE
- Employees: 70,000
- Website: https://www.bd.com
Latest SEC filings for BDX
Latest BDX news
- BDX Stock Gains 25.5% in Six Months: What's Behind the Rally? Read article
- Will Becton Dickinson (BDX) Beat Estimates Again in Its Next Earnings Report? Read article
- BDX Expands U.S. Manufacturing With $19B Healthcare Investment Read article
- Becton Dickinson Commits Massive $19 Billion To Expand Domestic Medical Manufacturing Read article
- Trump: Becton Dickinson agrees to invest $3B in US manufacturing, including $1B+ in Nebraska Read article
- Trump says Becton Dickinson to invest $3 billion to expand US medical product manufacturing Read article
- Zacks Industry Outlook Highlights McKesson, Cardinal Health, Becton, Dickinson, Merit Medical Systems and ProDex Read article
- Here's Why You Should Retain BDX Stock in Your Portfolio for Now Read article
Related companies
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.